InvestorsHub Logo
Followers 2
Posts 120
Boards Moderated 0
Alias Born 02/25/2012

Re: None

Monday, 09/15/2014 11:56:18 PM

Monday, September 15, 2014 11:56:18 PM

Post# of 233483
Big Pharma loves buying appealing small caps like CytoDyn, Inc. (NASDAQ: CYDY)

CytoDyn is a small cap biotech firm with a product developing well that could revolutionize the treatment of HIV patients.

That is a huge market with tremendous cost savings from the "drug holiday" treatment that CytoDyn hopes to bring to market. This is type product that, if approved, makes the host company very tempting.




Read more: http://www.benzinga.com/trading-ideas/long-ideas/14/04/4492163/3-ways-to-profit-from-merger-activity-in-the-pharmaceutical-s#ixzz3DRnmEhBn
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News